{"count":4,"index":{"built_at":"2026-07-27T01:52:21.938933+00:00","public_records":55311,"revision":"193596e9dda0408163fb1e35"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: CYP1A2 in the context of menopause"},"results":[{"answer":"The provided context documents do not contain specific information on CYP1A2 in relation to menopause. CYP1A2 is a well-studied gene involved in drug and caffeine metabolism, and it also plays a role in estrogen metabolism. During menopause, declining estrogen levels may reduce CYP1A2 activity, potentially increasing caffeine sensitivity. However, the evidence for direct clinical recommendations (e.g., adjusting caffeine intake based on genotype) is moderate, based mainly on pharmacokinetic and observational studies rather than robust RCTs. A consumer DNA test for CYP1A2 variants (e.g., rs762551) can indicate metabolic tendencies, but enzyme activity is also influenced by hormones, medications, and lifestyle. Without validated reference ranges for menopausal women, interpretation remains speculative. Consumers should approach such tests with caution and discuss results with a healthcare provider.","area":"gesundheit","canonical_id":"gesundheit:canonical-81de82ca1cb50a0825274b36","id":"public-188df6f77cc1ca83fc7da79c","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP1A2 in the context of menopause","score":23.03019616,"snippet":"The provided context documents do not contain specific information on CYP1A2 in relation to menopause. CYP1A2 is a well-studied gene involved in drug and caffeine metabolism, and it also plays a role in estrogen metabolism. During menopause, declining estrogen levels may reduce CYP1A2 activity, potentially increasing caffeine sensitivity. However, the evidence for direct clinical recommendations (e.g., adjusting caffeine intake based on genotype) is moderate, based mainly on pharmacokinetic and observational studies rather than robust RCTs. A consumer DNA test for CYP1A2 variants (e.g., rs762551) can indicate metabolic tendencies, but enzyme activity is also influenced by hormones, medicatio","sources":[],"title":"Evidence check: CYP1A2 in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-188df6f77cc1ca83fc7da79c/evidence-check-cyp1a2-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"CYP1A2 is a gene involved in the metabolism of caffeine and certain hormones, including estrogens. In the context of menopause, there is limited direct evidence linking CYP1A2 variants to clinically meaningful outcomes such as hot flashes or hormonal balance. Some research suggests a potential role in estrogen hydroxylation, but this remains mechanistic and not actionable. Consumer DNA tests often report CYP1A2 for caffeine sensitivity, but claims about menopause are speculative. The evidence is weak (mechanistic/unclear) and does not support personalized diet or supplement recommendations based solely on this gene. For menopause management, evidence-based strategies (HRT, lifestyle) should be prioritized. Caveat: direct-to-consumer marketing may overstate the relevance of single genes.","area":"gesundheit","canonical_id":"gesundheit:canonical-83334549de2aabdbfe18fd5a","id":"public-1b3a644c1e37a41c4d9efdab","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP1A2 in the context of Wechseljahre","score":22.76192887,"snippet":"CYP1A2 is a gene involved in the metabolism of caffeine and certain hormones, including estrogens. In the context of menopause, there is limited direct evidence linking CYP1A2 variants to clinically meaningful outcomes such as hot flashes or hormonal balance. Some research suggests a potential role in estrogen hydroxylation, but this remains mechanistic and not actionable. Consumer DNA tests often report CYP1A2 for caffeine sensitivity, but claims about menopause are speculative. The evidence is weak (mechanistic/unclear) and does not support personalized diet or supplement recommendations based solely on this gene. For menopause management, evidence-based strategies (HRT, lifestyle) should ","sources":[],"title":"Evidence check: CYP1A2 in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-1b3a644c1e37a41c4d9efdab/evidence-check-cyp1a2-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"CYP2C19 is an enzyme that metabolizes several drugs, including clopidogrel, proton pump inhibitors (e.g., omeprazole), and certain antidepressants (e.g., citalopram). A consumer DNA test indicates genetic predisposition, not actual enzyme activity. Clinical confirmation is required before any medication change. Regarding menopause, there is no strong evidence that CYP2C19 variants directly affect symptoms or hormone therapy. Estrogen metabolism is primarily mediated by CYP1A2, CYP3A4, and CYP2C9, not CYP2C19. For a 45-year-old woman in perimenopause, discussing medication interactions and individual risks with a physician is essential. A consumer test does not replace medical advice. Evidence: human-moderate for drug metabolism (CPIC guidelines), unclear for menopause. Caveat: never alter medications based solely on a consumer genetic test.","area":"gesundheit","canonical_id":"gesundheit:canonical-743ad65d2eae9824d9d9552a","id":"public-b290ac539f8ba3f3136941e2","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP2C19 in the context of menopause","score":21.19094282,"snippet":"CYP2C19 is an enzyme that metabolizes several drugs, including clopidogrel, proton pump inhibitors (e.g., omeprazole), and certain antidepressants (e.g., citalopram). A consumer DNA test indicates genetic predisposition, not actual enzyme activity. Clinical confirmation is required before any medication change. Regarding menopause, there is no strong evidence that CYP2C19 variants directly affect symptoms or hormone therapy. Estrogen metabolism is primarily mediated by CYP1A2, CYP3A4, and CYP2C9, not CYP2C19. For a 45-year-old woman in perimenopause, discussing medication interactions and individual risks with a physician is essential. A consumer test does not replace medical advice. Evidenc","sources":[],"title":"Evidence check: CYP2C19 in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-b290ac539f8ba3f3136941e2/evidence-check-cyp2c19-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The relationship between a Cardio Risk Check (cardiovascular risk test) and menopause (Wechseljahre) is not directly addressed in the provided context. Medically, menopause increases cardiovascular risk due to estrogen decline, affecting blood pressure, lipid profiles, and vascular function. A cardio risk check can be particularly relevant during this phase to identify early risk factors. However, the genetic markers mentioned in the context (e.g., CYP2C9 for warfarin dosing, CYP1A2 for caffeine, MTHFR for homocysteine, ALDH2 for alcohol metabolism, TAS2R38 for bitter taste) have no specific link to menopause. They pertain to other metabolic pathways and are not validated as menopause-specific risk markers. Therefore, the evidence for a direct connection between these particular DNA tests and menopause is unclear. A comprehensive risk assessment should include clinical parameters (blood pressure, lipids, fasting glucose) and lifestyle factors alongside genetic data. Interpretation requires medical guidance, especially during perimenopause.","area":"gesundheit","canonical_id":"gesundheit:canonical-dba57ce588eaf0504e5daffc","id":"public-1cba76d2e734dc592063d703","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and Wechseljahre related?","score":20.27534694,"snippet":"The relationship between a Cardio Risk Check (cardiovascular risk test) and menopause (Wechseljahre) is not directly addressed in the provided context. Medically, menopause increases cardiovascular risk due to estrogen decline, affecting blood pressure, lipid profiles, and vascular function. A cardio risk check can be particularly relevant during this phase to identify early risk factors. However, the genetic markers mentioned in the context (e.g., CYP2C9 for warfarin dosing, CYP1A2 for caffeine, MTHFR for homocysteine, ALDH2 for alcohol metabolism, TAS2R38 for bitter taste) have no specific link to menopause. They pertain to other metabolic pathways and are not validated as menopause-specif","sources":[],"title":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and Wechseljahre related?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-1cba76d2e734dc592063d703/how-are-cardio-risk-check-herz-kreislauf-risiko-test-and-wechseljahre-related/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}